These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23445537)

  • 1. Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis.
    Dolff S; Abdulahad WH; Arends S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2013 Feb; 15(1):R36. PubMed ID: 23445537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary T cells in active lupus nephritis show an effector memory phenotype.
    Dolff S; Abdulahad WH; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2010 Nov; 69(11):2034-41. PubMed ID: 20472588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.
    Kopetschke K; Klocke J; Grießbach AS; Humrich JY; Biesen R; Dragun D; Burmester GR; Enghard P; Riemekasten G
    Arthritis Res Ther; 2015 Apr; 17(1):94. PubMed ID: 25890061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4
    Klocke J; Kopetschke K; Grießbach AS; Langhans V; Humrich JY; Biesen R; Dragun D; Radbruch A; Burmester GR; Riemekasten G; Enghard P
    Eur J Immunol; 2017 Jan; 47(1):180-192. PubMed ID: 27753073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
    Front Immunol; 2020; 11():256. PubMed ID: 32265898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients.
    Wang H; Lan L; Chen J; Xiao L; Han F
    Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35973743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.
    Landolt-Marticorena C; Prokopec SD; Morrison S; Noamani B; Bonilla D; Reich H; Scholey J; Avila-Casado C; Fortin PR; Boutros PC; Wither J
    Arthritis Res Ther; 2016 Oct; 18(1):218. PubMed ID: 27716443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.
    Enghard P; Rieder C; Kopetschke K; Klocke JR; Undeutsch R; Biesen R; Dragun D; Gollasch M; Schneider U; Aupperle K; Humrich JY; Hiepe F; Backhaus M; Radbruch AH; Burmester GR; Riemekasten G
    Ann Rheum Dis; 2014 Jan; 73(1):277-83. PubMed ID: 23475982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.
    Nozaki Y; Kinoshita K; Yano T; Shiga T; Hino S; Niki K; Kishimoto K; Funauchi M; Matsumura I
    Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis.
    Jakiela B; Kosałka J; Plutecka H; Węgrzyn AS; Bazan-Socha S; Sanak M; Musiał J
    Lupus; 2018 Jul; 27(8):1259-1270. PubMed ID: 29653499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
    Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A
    Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
    Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
    Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of memory B- and T-cell subsets in lupus nephritis patients.
    Kosalka J; Jakiela B; Musial J
    Folia Histochem Cytobiol; 2016; 54(1):32-41. PubMed ID: 27094637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    Mesquita D; Kirsztajn GM; Franco MF; Reis LA; Perazzio SF; Mesquita FV; Ferreira VDS; Andrade LEC; de Souza AWS
    Clin Exp Immunol; 2018 Jan; 191(1):50-59. PubMed ID: 28945272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity.
    Stratigou V; Doyle AF; Carlucci F; Stephens L; Foschi V; Castelli M; McKenna N; Cook HT; Lightstone L; Cairns TD; Pickering MC; Botto M
    Rheumatology (Oxford); 2017 Jul; 56(7):1206-1216. PubMed ID: 28387859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
    Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
    Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.